V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 190008493 | 190002341 | 0 | 97.6 | Palliative (P) | 2016-01-21 | 2016-01-21 | GC Int Guide Excranial GermCell JEB | 02 | N | CNS ATRT DOX | 100458943 |
| 190008496 | 190002342 | null | null | null | null | 2019-06-19 | Carboplatin + Etoposide iv&po | null | null | CARBOPLATIN + ETOPOSIDE | 100687980 |
| 190008503 | 190002345 | 1.78 | 30.3 | Neo-adjuvant (N) | 2018-01-28 | 2018-03-12 | Trial Unspecified | null | null | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101781523 |
| 190008505 | 190002346 | null | null | null | null | 2020-02-12 | FLUOROURACIL + OXALIPLATIN | null | null | LIPOSOMAL DOXORUBICIN | 101726792 |
| 190008506 | 190002347 | 0 | 12.5 | Neo-adjuvant (N) | 2012-10-01 | 2012-10-21 | Cisplatin + Radiotherapy | 02 | Y | CISPLATIN | 100952611 |
| 190008512 | 190002351 | null | null | null | null | 2016-07-17 | Cisplatin + Gemcitabine (D 1 & 8) | null | null | CISPLATIN + GEMCITABINE | 100893307 |
| 190008529 | 190002357 | null | null | null | null | 2017-11-21 | Cisplatin + Gemcitabine (D 1 & 8) | null | null | CISPLATIN + GEMCITABINE | 101165907 |
| 190008533 | 190002358 | null | null | null | null | 2016-06-08 | GemCarbo Days 1+8 | null | null | CARBOPLATIN + GEMCITABINE | 100835135 |
| 190008538 | 190002360 | null | 133.8 | Palliative (P) | 2019-04-19 | 2019-04-28 | Carboplatin + Paclitaxel (3 weekly) | N | N | CARBOPLATIN + PACLITAXEL | 100795070 |
| 190008545 | 190002362 | 1.61 | 57 | Curative (C) | 2017-06-03 | 2017-06-10 | CAPECITABINE + OXALIPLATIN | 01 | N | CARBOPLATIN + FLUOROURACIL | 101346301 |
| 190008548 | 190002363 | 1.13 | 0 | Palliative (P) | 2021-09-04 | 2021-09-18 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | CARBOPLATIN + PACLITAXEL | 100117866 |
| 190008550 | 190002364 | 1.67 | 77 | Palliative (P) | 2018-10-04 | 2018-10-11 | EW EuroEwing 2012 Arm B VDC | Y | N | CISPLATIN + RT | 100797517 |
| 190008553 | 190002366 | null | null | null | null | 2018-10-18 | Dox + HD Mtx (post PAM) | null | null | PACLITAXEL | 101151809 |
| 190008554 | 190002367 | 1.75 | 85.5 | Curative (C) | 2017-12-18 | 2017-12-26 | Cisplatin + Doxorubicin | 02 | N | CISPLATIN + DOXORUBICIN | 100117030 |
| 190008556 | 190002368 | null | null | null | null | 2019-10-28 | EW EuroEwing 2012 Arm B VDC | null | null | EW EUROEWING 2012 ARM B VDC | 100729001 |
| 190008563 | 190002370 | 0 | 50.5 | Curative (C) | 2020-04-25 | 2020-04-30 | EW EuroEwing 2012 Arm B VDC | 02 | N | EW EUROEWING 2012 ARM B VDC | 101063328 |
| 190008567 | 190002371 | 1.7 | 61.5 | Palliative (P) | 2017-03-23 | 2017-03-23 | Cisplatin + Radiotherapy | 01 | N | EW EUROEWING 2012 ARM A VIDE | 100150432 |
| 190008569 | 190002372 | null | null | null | 2016-04-12 | 2016-04-16 | LANREOTIDE | 02 | null | PACLITAXEL | 101751172 |
| 190008570 | 190002373 | 1.67 | null | null | null | 2017-11-28 | Carboplatin AUC 2 - 5 | 02 | null | EW EUROEWING 2012 ARM A VIDE | 101455787 |
| 190008571 | 190002374 | 1.67 | 87.1 | Curative (C) | 2018-09-18 | 2018-09-26 | LUTETIUM-177 | 02 | N | EW EUROEWING 2012 ARM A VIDE | 101448400 |
| 190008572 | 190002375 | null | null | Curative (C) | null | 2016-05-24 | Carboplatin AUC 2 - 5 | null | null | DOXORUBICIN + HD MTX | 101317442 |
| 190008575 | 190002377 | 1.57 | 29.5 | Curative (C) | 2017-06-26 | 2017-06-26 | Cisplatin + Radiotherapy | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | 101320016 |
| 190008579 | 190002379 | 1.57 | 63 | Curative (C) | 2020-01-18 | 2020-01-20 | OST Euramos 1 Closed Trial - AP | 02 | N | OST AP | 101327356 |
| 190008584 | 190002381 | 0 | 32 | Curative (C) | 2019-09-25 | 2019-09-25 | GemCarbo Days 1+8 | 02 | N | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE | 101114690 |
| 190008586 | 190002382 | 1.7 | 97.8 | Palliative (P) | 2018-01-16 | 2018-01-21 | LANREOTIDE | 02 | N | DOXORUBICIN + METHOTREXATE | 100356929 |
| 190008587 | 190002383 | null | null | null | null | 2019-10-23 | OST Euramos 1 Closed Trial - AP | null | null | OST AP | 100220016 |
| 190008589 | 190002384 | null | null | null | null | 2018-06-03 | MAP | null | null | CISPLATIN + DOXORUBICIN + METHOTREXATE | 100851072 |
| 190008601 | 190002385 | 1.81 | null | Curative (C) | 2021-04-18 | 2021-04-18 | Cisplatin + Doxorubicin | 02 | N | CISPLATIN + DOXORUBICIN | 101424866 |
| 190008608 | 190002386 | 1.49 | 72.8 | Palliative (P) | 2018-10-06 | 2018-10-31 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 02 | N | MAP | 100150733 |
| 190008609 | 190002387 | 1.8 | 79 | Curative (C) | 2018-03-20 | 2018-03-22 | OST Euramos 1 Closed Trial - AP | 02 | N | OST AP | 101054051 |
| 190008610 | 190002388 | null | 59 | Palliative (P) | 2020-01-01 | 2020-01-10 | Cisplatin+Doxorubicin+Etoposide 28d | 02 | N | LANREOTIDE | 101047466 |
| 190008612 | 190002389 | 1.78 | 71.6 | Curative (C) | 2017-03-10 | 2017-03-16 | CARBOPLATIN + RT | 02 | N | CARBOPLATIN + ETOPOSIDE | 100246288 |
| 190008614 | 190002390 | 1.54 | 55.2 | null | 2018-04-09 | 2018-04-13 | EW EuroEwing 2012 Arm A VIDE | null | null | EURO-EWING | 100353650 |
| 190008624 | 190002392 | 1.65 | 68.9 | 03 | 2018-10-20 | 2018-10-26 | EURAMOS TRIAL | 2 | Y | MAP | 100021931 |
| 190008626 | 190002393 | null | null | null | null | 2017-11-09 | FLUOROURACIL + OXALIPLATIN | null | null | EURAMOS TRIAL | 100506170 |
| 190008629 | 190002394 | 1.69 | 65 | Palliative (P) | 2019-06-08 | 2019-07-28 | Cisplatin + Doxorubicin | N | N | CISPLATIN + DOXORUBICIN | 101008642 |
| 190008637 | 190002398 | null | null | null | null | 2018-08-08 | PAM x 2 post-surgery (cycles 3&4) | null | null | CISPLATIN + DOXORUBICIN + METHOTREXATE | 100812108 |
| 190008638 | 190002399 | null | null | null | null | 2018-11-23 | OST Euramos 1 Closed Trial - AP | null | null | OST AP | 101067062 |
| 190008644 | 190002401 | 1.67 | 71 | Palliative (P) | 2019-11-05 | 2019-11-08 | Cisplatin + Doxorubicin | 02 | N | CISPLATIN + DOXORUBICIN | 101621193 |
| 190008646 | 190002402 | 1.74 | 71 | Curative (C) | 2021-01-28 | 2021-01-28 | EW EuroEwing 2012 Arm B VDC | 01 | Y | EW EUROEWING 2012 ARM B VDC | 100578009 |
| 190008647 | 190002403 | 1.59 | 61.4 | Curative (C) | 2018-09-26 | 2018-09-26 | NB Low/Interm risk guidelines Carbo/Etop | 02 | N | EW EUROEWING 2012 ARM A VIDE | 100996805 |
| 190008662 | 190002408 | null | null | null | null | 2017-10-01 | Dox + HD Mtx (post PAM) | null | null | CASPS TRIAL | 101698207 |
| 190008669 | 190002411 | 0 | 50.5 | Palliative (P) | 2020-07-16 | 2020-07-18 | ECX | Y | N | CARBOPLATIN + ETOPOSIDE | 100338900 |
| 190008671 | 190002412 | 1.66 | 105.8 | null | 2017-05-27 | 2017-06-11 | Cisplatin + Doxorubicin | 02 | null | CISPLATIN + DOXORUBICIN | 101855085 |
| 190008672 | 190002413 | 1.56 | 80.6 | Palliative (P) | 2016-08-01 | 2016-08-03 | ECX | 01 | N | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 100998521 |
| 190008674 | 190002415 | 0 | 72.2 | Curative (C) | 2020-02-28 | 2020-03-06 | Carboplatin+Fluorouracil 4 or 5 day | N | null | DOXORUBICIN + METHOTREXATE | 100088370 |
| 190008678 | 190002417 | 1.75 | 50.1 | Palliative (P) | 2018-06-17 | 2018-06-19 | Carboplatin AUC 2 - 5 | 02 | N | EURO-EWING | 100754361 |
| 190008681 | 190002419 | 1.55 | 94.5 | Curative (C) | 2019-11-20 | 2019-12-19 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 01 | N | DOXORUBICIN + HD MTX | 100685833 |
| 190008687 | 190002420 | null | null | null | null | 2018-04-15 | Carboplatin AUC 6 - 10 | null | null | TRIAL | 101280432 |
| 190008691 | 190002421 | 1.53 | 110 | Palliative (P) | 2020-05-08 | 2020-05-11 | Cisplatin + Doxorubicin | N | N | CISPLATIN + DOXORUBICIN | 100325113 |